News
12-14-2009, 07:10 AM
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that researchers who participated in the breast cancer arm of a Phase 3 clinical evaluation of Lymphoseek® presented data from their clinical experience at the International San Antonio Breast Cancer Symposium...
More... (http://www.medicalnewstoday.com/articles/173924.php)
More... (http://www.medicalnewstoday.com/articles/173924.php)